Skip to content
★ Sign in to follow
LP

Lawrence P. Wennogle

CEO
Intra-Cellular Therapies, Inc.
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€1.1M

Latest filing published 09 Jun 2015 for Intra-Cellular Therapies, Inc., €595k.

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

No signal scores available.

Lawrence P. Wennogle: trading record in brief

Lawrence P. Wennogle appears in our data through filings on Intra-Cellular Therapies, Inc. shares, published by SEC (Form 4). The record holds 17 filings, for trades running from 16 December 2013 to 8 June 2015.

Sales make up the whole of the open-market record (11 sales, €1.1M). Outside the open market, there are 6 option exercises. 2015 to date brings no purchases and 1 sale.

Most recently, on 9 June 2015, the filings show an open-market sale worth €595k in Intra-Cellular Therapies, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Lawrence P. Wennogle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations